1. Home
  2. HFFG vs CGEN Comparison

HFFG vs CGEN Comparison

Compare HFFG & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HF Foods Group Inc.

HFFG

HF Foods Group Inc.

HOLD

Current Price

$2.10

Market Cap

127.8M

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.05

Market Cap

148.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFFG
CGEN
Founded
1997
1993
Country
United States
Israel
Employees
960
N/A
Industry
Food Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.8M
148.7M
IPO Year
2016
2001

Fundamental Metrics

Financial Performance
Metric
HFFG
CGEN
Price
$2.10
$2.05
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
215.1K
286.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,201,667,000.00
N/A
Revenue This Year
$4.36
N/A
Revenue Next Year
$3.35
$58.57
P/E Ratio
N/A
N/A
Revenue Growth
4.63
N/A
52 Week Low
$1.38
$1.13
52 Week High
$4.93
$2.38

Technical Indicators

Market Signals
Indicator
HFFG
CGEN
Relative Strength Index (RSI) 63.80 60.79
Support Level $1.38 $1.43
Resistance Level $2.37 $2.38
Average True Range (ATR) 0.16 0.13
MACD 0.09 0.04
Stochastic Oscillator 81.82 61.79

Price Performance

Historical Comparison
HFFG
CGEN

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: